Format

Send to

Choose Destination
Semin Perinatol. 2016 Oct;40(6):348-355. doi: 10.1053/j.semperi.2016.05.010.

Prevention and management of bronchopulmonary dysplasia: Lessons learned from the neonatal research network.

Author information

1
Department of Pediatrics, University of Texas Medical School at Houston, Houston, TX. Electronic address: Kathleen.A.Kennedy@uth.tmc.edu.
2
Department of Pediatrics, Duke University, Durham, NC.
3
University of New Mexico Health Sciences Center, Albuquerque, NM.
4
Division of Neonatology, University of Alabama at Birmingham, Birmingham, AL.

Abstract

Despite remarkable improvements in survival of extremely premature infants, the burden of BPD among survivors remains a frustrating problem for parents and caregivers. Advances, such as antenatal steroids and surfactant replacement, which have dramatically improved survival, have not reduced BPD among survivors. Other advances that have significantly improved the combined outcome of death or BPD, such as vitamin A and avoidance of mechanical ventilation, have had smaller magnitude effects on the outcome of BPD alone. Postnatal steroids have a clear beneficial effect on BPD, but the optimal preparation, dose, and timing for maximizing benefit and minimizing harm have yet to be determined. This persistent burden of BPD among the most immature survivors remains a challenge for the NRN and other researchers in neonatal medicine.

KEYWORDS:

Bronchopulmonary dysplasia; Corticosteroids; Ventilation

PMID:
27742002
PMCID:
PMC5279709
DOI:
10.1053/j.semperi.2016.05.010
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center